A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals.

Trial Profile

A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs Ritonavir (Primary) ; Atazanavir; Atazanavir/ritonavir; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Nevirapine; Tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Acronyms STAR-2
  • Most Recent Events

    • 16 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top